The store will not work correctly when cookies are disabled.
2-(3,4-dimethoxyphenyl)-5-(2-(1-methyl-1H-pyrazol-4-yl)-5-(trifluoromethoxy)phenyl)-1,3,4-oxadiazole
ID: ALA4553780
PubChem CID: 155555880
Max Phase: Preclinical
Molecular Formula: C21H17F3N4O4
Molecular Weight: 446.39
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(-c2nnc(-c3cc(OC(F)(F)F)ccc3-c3cnn(C)c3)o2)cc1OC
Standard InChI: InChI=1S/C21H17F3N4O4/c1-28-11-13(10-25-28)15-6-5-14(32-21(22,23)24)9-16(15)20-27-26-19(31-20)12-4-7-17(29-2)18(8-12)30-3/h4-11H,1-3H3
Standard InChI Key: ZFKPRJZBVPNLEF-UHFFFAOYSA-N
Molfile:
RDKit 2D
32 35 0 0 0 0 0 0 0 0999 V2000
33.9492 -13.2979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9480 -14.1174 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6561 -14.5264 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3657 -14.1170 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3629 -13.2943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6543 -12.8890 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6518 -12.0718 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.3583 -11.6611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3559 -10.8440 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
36.0672 -12.0676 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
36.0637 -11.2467 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
36.0741 -14.5244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1613 -15.3346 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.9609 -15.5032 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.3684 -14.7948 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8206 -14.1885 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.1851 -14.7920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5941 -15.5001 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.4100 -15.4976 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.8167 -14.7884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.4015 -14.0802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5869 -14.0862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.6339 -14.7844 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
41.0459 -15.4902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.8051 -13.3697 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
40.6223 -13.3639 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6559 -15.3436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9996 -15.8237 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2520 -16.6010 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.0692 -16.6012 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.3218 -15.8241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5495 -17.2624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
6 7 1 0
7 8 1 0
8 9 1 0
8 10 1 0
8 11 1 0
4 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 12 1 0
15 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
20 23 1 0
23 24 1 0
21 25 1 0
25 26 1 0
3 27 1 0
27 28 1 0
28 29 2 0
29 30 1 0
30 31 1 0
31 27 2 0
30 32 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 446.39 | Molecular Weight (Monoisotopic): 446.1202 | AlogP: 4.72 | #Rotatable Bonds: 6 |
Polar Surface Area: 84.43 | Molecular Species: NEUTRAL | HBA: 8 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 1.80 | CX LogP: 4.20 | CX LogD: 4.20 |
Aromatic Rings: 4 | Heavy Atoms: 32 | QED Weighted: 0.42 | Np Likeness Score: -1.16 |
References
1. Reed CW, Washecheck JP, Quitlag MC, Jenkins MT, Rodriguez AL, Engers DW, Blobaum AL, Conn PJ, Niswender CM, Lindsley CW.. (2019) Surveying heterocycles as amide bioisosteres within a series of mGlu7 NAMs: Discovery of VU6019278., 29 (10): [PMID:30910459] [10.1016/j.bmcl.2019.03.016] |